89 related articles for article (PubMed ID: 1753437)
21. A single base mutation in the 5' splice site of intron 7 of the lck gene is responsible for the deletion of exon 7 in lck mRNA of the JCaM1 cell line.
Rouer E; Brule F; Benarous R
Oncogene; 1999 Jul; 18(29):4262-8. PubMed ID: 10435639
[TBL] [Abstract][Full Text] [Related]
22. [Partial deletion of alpha-galactosidase A gene in a Japanese mutant of Fabry disease].
Sakuraba H; Bishop DF; Suzuki T; Suzuki Y; Desnick RJ
No To Hattatsu; 1990 May; 22(3):247-52. PubMed ID: 2163664
[TBL] [Abstract][Full Text] [Related]
23. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
24. The gene encoding alpha-galactosidase A and gene rearrangements causing Fabry disease.
Kornreich R; Bishop DF; Desnick RJ
Trans Assoc Am Physicians; 1989; 102():30-43. PubMed ID: 2561643
[No Abstract] [Full Text] [Related]
25. Exon skipping caused by a base substitution at a splice site in the GTP cyclohydrolase I gene in a Japanese family with hereditary progressive dystonia dopa responsive dystonia.
Hirano M; Tamaru Y; Nagai Y; Ito H; Imai T; Ueno S
Biochem Biophys Res Commun; 1995 Aug; 213(2):645-51. PubMed ID: 7544125
[TBL] [Abstract][Full Text] [Related]
26. Characterization of an intron 12 splice donor mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
Strong TV; Smit LS; Nasr S; Wood DL; Cole JL; Iannuzzi MC; Stern RC; Collins FS
Hum Mutat; 1992; 1(5):380-7. PubMed ID: 1284540
[TBL] [Abstract][Full Text] [Related]
27. Invariant exon skipping in the human alpha-galactosidase A pre-mRNA: Ag+1 to t substitution in a 5'-splice site causing Fabry disease.
Sakuraba H; Eng CM; Desnick RJ; Bishop DF
Genomics; 1992 Apr; 12(4):643-50. PubMed ID: 1315304
[TBL] [Abstract][Full Text] [Related]
28. Characterization of hprt splicing mutations induced by the ultimate carcinogenic metabolite of benzo[a]pyrene in Chinese hamster V-79 cells.
Hennig EE; Conney AH; Wei SJ
Cancer Res; 1995 Apr; 55(7):1550-8. PubMed ID: 7882364
[TBL] [Abstract][Full Text] [Related]
29. Mutation analysis of alpha-galactosidase a gene in Hungarian Fabry patients.
László A; Török L; Raffai S; Török E; Sallay E; Endreffy E; Morvai L; van Amstel JK
Ideggyogy Sz; 2012 Jan; 65(1-2):35-9. PubMed ID: 22338844
[TBL] [Abstract][Full Text] [Related]
30. Identification of a point mutation and germinal mosaicism in a Duchenne muscular dystrophy family.
Wilton SD; Chandler DC; Kakulas BA; Laing NG
Hum Mutat; 1994; 3(2):133-40. PubMed ID: 8199594
[TBL] [Abstract][Full Text] [Related]
31. Fabry disease in a female patient due to a de novo point mutation at position 691 of exon 5.
Brokalaki EI; Hentschke M; Grabbe S; Jansen T
Eur J Med Res; 2006 Jul; 11(7):306-8. PubMed ID: 16899426
[TBL] [Abstract][Full Text] [Related]
32. Alternative splicing in the alpha-galactosidase A gene: increased exon inclusion results in the Fabry cardiac phenotype.
Ishii S; Nakao S; Minamikawa-Tachino R; Desnick RJ; Fan JQ
Am J Hum Genet; 2002 Apr; 70(4):994-1002. PubMed ID: 11828341
[TBL] [Abstract][Full Text] [Related]
33. A case of Fabry's disease in a patient with no alpha-galactosidase A activity caused by a single amino acid substitution of Pro-40 by Ser.
Koide T; Ishiura M; Iwai K; Inoue M; Kaneda Y; Okada Y; Uchida T
FEBS Lett; 1990 Jan; 259(2):353-6. PubMed ID: 2152885
[TBL] [Abstract][Full Text] [Related]
34. Analysis of splice-site mutations of the alpha-galactosidase A gene in Fabry disease.
Lai LW; Whitehair O; Wu MJ; O'Meara M; Lien YH
Clin Genet; 2003 Jun; 63(6):476-82. PubMed ID: 12786754
[TBL] [Abstract][Full Text] [Related]
35. Structural organization and expression of the mouse gene encoding alpha-galactosidase A.
Ohshima T; Murray GJ; Nagle JW; Quirk JM; Kraus MH; Barton NW; Brady RO; Kulkarni AB
Gene; 1995 Dec; 166(2):277-80. PubMed ID: 8543175
[TBL] [Abstract][Full Text] [Related]
36. Alpha-galactosidase A gene rearrangements causing Fabry disease. Identification of short direct repeats at breakpoints in an Alu-rich gene.
Kornreich R; Bishop DF; Desnick RJ
J Biol Chem; 1990 Jun; 265(16):9319-26. PubMed ID: 2160973
[TBL] [Abstract][Full Text] [Related]
37. Structural organization of the human alpha-galactosidase A gene: further evidence for the absence of a 3' untranslated region.
Bishop DF; Kornreich R; Desnick RJ
Proc Natl Acad Sci U S A; 1988 Jun; 85(11):3903-7. PubMed ID: 2836863
[TBL] [Abstract][Full Text] [Related]
38. Unbalanced GLA mRNAs ratio quantified by real-time PCR in Fabry patients' fibroblasts results in Fabry disease.
Filoni C; Caciotti A; Carraresi L; Donati MA; Mignani R; Parini R; Filocamo M; Soliani F; Simi L; Guerrini R; Zammarchi E; Morrone A
Eur J Hum Genet; 2008 Nov; 16(11):1311-7. PubMed ID: 18560446
[TBL] [Abstract][Full Text] [Related]
39. Twenty novel mutations in the alpha-galactosidase A gene causing Fabry disease.
Topaloglu AK; Ashley GA; Tong B; Shabbeer J; Astrin KH; Eng CM; Desnick RJ
Mol Med; 1999 Dec; 5(12):806-11. PubMed ID: 10666480
[TBL] [Abstract][Full Text] [Related]
40. Fabry disease: novel alpha-galactosidase A 3'-terminal mutations result in multiple transcripts due to aberrant 3'-end formation.
Yasuda M; Shabbeer J; Osawa M; Desnick RJ
Am J Hum Genet; 2003 Jul; 73(1):162-73. PubMed ID: 12796853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
